FILING RADAR

Connecting to SEC EDGAR… Pricing Sign in

← All filings

DRMA

Dermata Therapeutics, Inc. SEC filings

Pharmaceutical Preparations · Nasdaq · Incorporated in DE

On the radar right now · 0

Nothing in the live feed for DRMA right now.

Filing history

2026-11-02

Passive 5%+ stake SCHEDULE 13G

2026-10-29

Current report 8-K

Other event

2026-10-21

Prospectus 424B3

2026-10-20

EFFECT EFFECT

2026-10-09

Shelf registration (future share sales) S-3

2026-08-18

Insider trade 4

2026-08-18

Insider trade 4

2026-08-17

Delisting notice (exchange) 25-NSE

2026-08-17

Current report 8-K

Material agreementShare sale (dilution)Other event

2026-08-11

Quarterly report 10-Q

2026-08-11

Current report 8-K

Earnings results

2026-08-05

Current report 8-K

Other event

2026-06-16

Insider trade 4

2026-06-04

Employee stock plan shares S-8

2026-06-01

5%+ stake, may push for changes SCHEDULE 13D

2026-05-29

EFFECT EFFECT

2026-05-29

Prospectus 424B3

2026-05-27

Current report 8-K

Exec/director changeShareholder vote

2026-05-27

CORRESP CORRESP

2026-05-22

S-3/A S-3/A

2026-05-13

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-13

Quarterly report 10-Q

2026-05-13

Current report 8-K

Earnings results

2026-04-22

Passive 5%+ stake update SCHEDULE 13G/A

2026-04-17

Annual report to shareholders ARS

2026-04-17

Proxy material DEFA14A

2026-04-17

Proxy statement (shareholder vote) DEF 14A

2026-04-07

PRE 14A PRE 14A

2026-03-26

Annual report 10-K

2026-03-26

Current report 8-K

Earnings results

2026-03-17

Insider trade 4

2026-02-25

Current report 8-K

Exec/director change

2026-02-23

5%+ stake update (13D) SCHEDULE 13D/A

2026-02-18

Passive 5%+ stake update SCHEDULE 13G/A

2026-02-17

Passive 5%+ stake update SCHEDULE 13G/A

2026-02-09

Passive 5%+ stake update SCHEDULE 13G/A

2026-02-03

Current report 8-K

Auditor change

2026-02-02

5%+ stake update (13D) SCHEDULE 13D/A

2026-01-29

EFFECT EFFECT

2026-01-29

Prospectus 424B3